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nvasive tumor dissemination in vitro and in vivo involves
the proteolytic degradation of ECM barriers. This process,
however, is only incompletely attenuated by protease
inhibitor–based treatment, suggesting the existence of
migratory compensation strategies. In three-dimensional
collagen matrices, spindle-shaped proteolytically potent
HT-1080 ﬁbrosarcoma and MDA-MB-231 carcinoma cells
exhibited a constitutive mesenchymal-type movement
including the coclustering of 
 
 
 
1 integrins and MT1–matrix
metalloproteinase (MMP) at ﬁber bindings sites and the
generation of tube-like proteolytic degradation tracks.
Near-total inhibition of MMPs, serine proteases, cathepsins,
and other proteases, however, induced a conversion toward
spherical morphology at near undiminished migration
rates. Sustained protease-independent migration resulted
I
 
from a ﬂexible amoeba-like shape change, i.e., propulsive
squeezing through preexisting matrix gaps and formation
of constriction rings in the absence of matrix degradation,
concomitant loss of clustered 
 
 
 
1 integrins and MT1-MMP
from ﬁber binding sites, and a diffuse cortical distribution
of the actin cytoskeleton. Acquisition of protease-independent
amoeboid dissemination was conﬁrmed for HT-1080 cells
injected into the mouse dermis monitored by intravital
multiphoton microscopy. In conclusion, the transition from
proteolytic mesenchymal toward nonproteolytic amoeboid
movement highlights a supramolecular plasticity mechanism
in cell migration and further represents a putative escape
mechanism in tumor cell dissemination after abrogation of
pericellular proteolysis.
 
Introduction
 
The invasion and migration of tumor cells involves coordi-
nated adhesion as well as proteolytic interaction with the
ECM substrate, resulting in the degradation and remodeling
of interstitial tissue barriers (Stetler-Stevenson et al., 1993).
Upon tumor progression, multiple classes of ECM-degrading
enzymes are up-regulated and activated, including matrix
metalloproteinases (MMPs),* serine proteases, and cathepsins
(Birkedal-Hansen, 1995). Fibrillar collagen, the main con-
stituent of the connective tissue matrix is degraded by several
proteases, including MMP-1, -2, -8, and -13, membrane-
anchored MT1-MMP, MT3-MMP, and cathepsin B, K,
and L (Montcourrier et al., 1990; Aimes and Quigley, 1995;
Ohuchi et al., 1997; Sassi et al., 2000). Accordingly, tumor
cells expressing MMPs and other proteases generate proteolytic
substrate degradation along their migration tracks on gelatin,
matrigel, or fibronectin (Nakahara et al., 1997; d’Ortho et
al., 1998). Blocking of MMPs and other proteases by pharma-
cological compounds impairs invasive tumor cell behavior in
different migration and invasion models in vitro (Mignatti et
al., 1986; Kurschat et al., 1999; Ntayi et al., 2001) as well as
experimental metastasis in vivo (Coussens et al., 2002; and
references therein). Together, these findings support a concept
on proteolytic path generation favoring tumor cell dissemi-
nation within the tissues (Murphy and Gavrilovic, 1999;
Friedl and Bröcker, 2000).
 
The online version of this article includes supplemental material.
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*Abbreviations used in this paper: 2-, 3-, and 4D, two, three, and four
dimensional; MAT, mesenchymal–amoeboid transition; MMP, matrix
metalloproteinase; uPA, urokinase-type plasminogen activator; uPAR,
receptor for uPA.
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Conversely, accumulating evidence suggests that, despite
their established proinvasive function, ECM-degrading en-
zymes could be dispensable for tumor cell motility and dis-
semination. After blocking of MMPs or serine proteases, sig-
nificant residual migration of individual cells is observed in
different migration models (Deryugina et al., 1997; Hiraoka
et al., 1998; Kurschat et al., 1999; Ntayi et al., 2001). In
vivo, protease inhibitor–based targeting of MMPs and serine
proteases has prompted an unexpectedly weak benefit in
some animal tumor models as well as clinical trials in hu-
mans, suggesting that a principal dissemination capacity re-
mained intact (Della et al., 1999; Zucker et al., 2000;
Kruger et al., 2001; Coussens et al., 2002). These studies,
however, leave unresolved by which mechanisms cells may
maintain migratory dissemination in the absence of ECM-
degrading capacity. As one possibility, proteolytic compen-
sation could be provided by enzymes not inhibited in these
studies; alternatively, cells could sustain motility via un-
known protease-independent compensation strategies.
To understand how proteases contribute to cell migration,
the concept of pericellular proteolysis has to be integrated
into the current paradigm on cell migration as a supramolec-
ular process (Lauffenburger and Horwitz, 1996; Friedl and
Bröcker, 2000). Cell migration results from a three-step cy-
cle of polarized cell extension and substrate binding through
leading pseudopod(s), followed by actin-based contraction
of the cell body and release of adhesive bonds at the trailing
edge (Palecek et al., 1997). Adhesive interaction and traction
toward the ECM substrate are generated by adhesion recep-
tors predominantly of the 
 
 
 
1 and 
 
 
 
3 integrin families
(Brooks et al., 1996; Palecek et al., 1997; Sheetz et al.,
1998). After binding to extracellular scaffolds, integrins
cluster and couple to the actin cytoskeleton to further
strengthen cell–ECM linkages, which generates bipolar trac-
tion between anterior and posterior cell edges to elongate the
cell body toward a spindle-shaped morphology (Sheetz et al.,
1998; Maaser et al., 1999). For focalized degradation of
ECM substrata, integrins cooperate with cell surface pro-
teases. In invasive tumor cells, 
 
 
 
v
 
 
 
3 integrin colocalizes
with MMP-2 (Brooks et al., 1996) and 
 
 
 
1 integrins coclus-
ter with MT1-MMP (Belkin et al., 2001), as well as the re-
ceptor for urokinase-type plasminogen activator (uPAR)
(Wei et al., 1996). Accordingly, overexpression of uPAR and
MT-MMPs favor integrin-mediated motility and invasion
in two-dimensional (2D) and three-dimensional (3D) ECM
models, respectively (Wei et al., 1996; Hiraoka et al., 1998).
Consistent with migration-associated proteolysis, integrin-
dependent migration of tumor cells results in the formation
of tube-like matrix defects that represent paths of least resis-
tance for the advancing cell body (Friedl et al., 1997). How-
ever, although proteolytic ECM degradation accompanies
and augments tumor invasion and motility, it remains to be
clarified whether pericellular proteolysis is indeed indispens-
able for the penetration of interstitial matrix barriers.
 
Figure 1.
 
Proteolytic migration of HT-1080/MT1 fibrosarcoma 
cells in 3D collagen lattice.
 
 (A) Morphology of HT-1080/MT1 cell 
migrating through 3D collagen lattice monitored by video microscopy. 
(B) Reduction of migration speed (black bars) and induction of 
detached, nonmobile spherical morphology (inset) by adhesion-
perturbing anti–
 
 
 
1 integrin antibody 4B4. (C) Confocal backscatter 
(matrix fibers) and fluorescence of MT1-MMP (red), 
 
 
 
1 integrins 
(green), and colocalization (yellow; arrowheads) at fiber traction 
zone of the leading edge. (D) 3D reconstruction of a calcein-stained 
migrating cell by time-lapse confocal microscopy and (E) backscatter 
signal of the same cell from the central section (time, 60 min). Fiber 
bundling (white arrowheads), deposition of cell fragments (black 
arrowhead), and newly formed matrix defect (asterisk). Black arrows, 
direction of migration. Bars, 20 
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In the present study, using proteolytic tumor cells migrat-
ing through 3D fibrillar collagen-rich matrix in vitro and in
vivo, we have investigated to what extent abrogation of
ECM-degrading capacity, including the blocking of MMPs,
serine proteases, and cathepsins, impairs the migratory action.
By means of time-lapse videomicroscopy and four-dimen-
sional (4D) confocal and multiphoton microscopy, we have
particularly focused on the mechanisms of residual tumor
cell movement after protease function was antagonized.
 
Results
 
HT-1080 fibrosarcoma cells overexpressing the membrane-
localized MT1-MMP (Deryugina et al., 1997, 1998) and
MDA-MB-231 mammary carcinoma cells (Ishibashi et al.,
1999; Bachmeier et al., 2001) were used as metastatic tumor
cells capable of efficiently degrading and invading the ECM.
 
A mesenchymal type of tumor cell migration
 
In 3D collagen matrices, the migration of HT-1080/MT1
cells was characterized by polarized binding of the lead-
ing edge to collagen fibers, generating traction and spin-
dle-shaped elongation of the cell body (Fig. 1 A; Video 1
A, available online at http://www.jcb.org/cgi/content/full/
jcb.200209006/DC1). Both polarization and migration
were abrogated by adhesion-perturbing anti–
 
 
 
1 integrin
mAb 4B4 (Fig. 1 B; Video 1 B), confirming 
 
 
 
1 integrin–
mediated migratory force generation. MT1-MMP and 
 
 
 
1
integrins were coclustered at interaction sites to collagen fi-
bers (Fig. 1 C), which represented the location of initial fiber
binding, traction, and bundling toward the leading edge
(Fig. 1, D and E, white arrowheads; Video 2, available on-
line at http://www.jcb.org/cgi/content/full/jcb.200209006/
DC1). Upon forward movement of the cell body, the de-
tachment of the trailing edge generated a circumscribed ma-
trix defect that was bordered by aligned multifibrillar col-
lagen bundles (Fig. 1 E, asterisks; Video 2). Cell detachment
was further accompanied by the shedding of surface deter-
minants and cell fragments along the migration track (Fig. 1
D, black arrowhead). This mesenchymal migration type of
spindle-shaped cells that produce matrix defects is consistent
with the integrin-dependent haptokinetic migration re-
ported for fibroblasts (Doane and Birk, 1991; Palecek et al.,
1997) and further supports the concept of focalized pericel-
lular proteolysis for the generation of migration tracks (Mur-
phy and Gavrilovic, 1999).
 
Inhibition of collagenolysis by protease inhibitor cocktail
 
Pericellular degradation of native or denatured collagens can
be directly or indirectly provided by proteases from different
classes, including MMPs, serine proteases (e.g., plasmin and
urokinase-type plasminogen activator [uPA]), as well as cys-
teine and aspartic proteases (e.g., cathepsins) (Montcourrier
et al., 1990; Aimes and Quigley, 1995; Ohuchi et al., 1997;
Sassi et al., 2000). In addition to MT1-MMP, many of these
proteases, including up to five other collagenases toward na-
tive type collagen (Fig. 2 A, asterisks), were expressed by
HT-1080/MT1 cells, as detected by RT-PCR. Because col-
lagenolytic redundancy was anticipated, we used a cocktail of
broad-spectrum protease inhibitors to simultaneously target
a wide spectrum of endoproteolytic activity (Table I). To
maintain sufficient inhibitory activity within the matrix, the
employed concentrations of protease inhibitors were orders
of magnitudes higher than the known maximum inhibitory
values, unless cell viability was dose limiting (Table I). Be-
cause most of the proteases detectable by RT-PCR escape vi-
Figure 2. Protease expression in HT-
1080/MT1 cells and inhibition of 
collagenolysis. (A) mRNA expression 
of MMPs, ADAMs, cathepsins, and 
serine proteases detected by RT-PCR. 
Asterisks, proteases cleaving native type I 
collagen. (B) Degradation of 3D fibrillar 
collagen by HT1080/MT1 cells (500,000 
cells) layered on top of a 1-mm-thick 
collagen matrix in the absence (1) or 
presence (2) of protease inhibitor cocktail. 
(B, 3) Confocal backscatter of lysis zone 
bordered by clumped collagen, as indi-
cated by the square in (1). (B, 4) Negative 
control matrix overlaid with cell-free 
medium only. (C) Cell contact to FITC-
labeled collagen fibers; confocal reflection 
(gray) and FITC fluorescence (green). 
Bar, 20  m. (D) Migration-associated 
collagenolysis caused by HT1080/MT1 
cells within 3D FITC–collagen lattices 
was quantified from the FITC release 
after 40 h of migration in the absence 
or presence of inhibitors. ***, P   0.001; 
two-tailed t test for independent means, 
difference to control cells. As negative 
control, T cells did not release FITC 
above background levels (not depicted).T
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sualization by zymography (Deryugina et al., 1997, 1998;
Ntayi et al., 2001), inhibition of cell-dependent collagenoly-
sis in situ was measured using the fibrillar collagen migration
substrate as read-out. On a qualitative basis, structural break-
down of the matrix fibers caused by HT-1080/MT1 cells
(Fig. 2 B, 1 and 3) was fully abrogated in the presence of
protease inhibitor cocktail (Fig. 2 B, 2). This strong inhibi-
tory effect was confirmed by a quantitative 3D fluorometric
 
fluorescein (FITC) release assay, detecting the degradation of
FITC-labeled collagen fibers (Fig. 2 C). Upon migration
within FITC–collagen, HT-1080/MT1 cells released 20%
of the total FITC content (Fig. 2 D), confirming the ob-
served macroscopic (Fig. 2 B, 1) and microscopic collagen fi-
ber degradation (Fig. 1 E; Fig. 2 B, 3). Protease inhibitor
cocktail inhibited 95% of the cell-mediated FITC release
generated by HT-1080/MT1 cells (Fig. 2 D) and to the
same residual level in vector-transfected HT-1080/
 
neo
 
 cells
(unpublished data). Broad-range MMP inhibitor BB-2516
(marimastat) alone abrogated 
 
 
 
80% of the FITC release in
HT-1080/MT1 cells, suggesting a major contribution of
MMPs to the degradation of collagen (Fig. 2 D).
Unexpectedly, although inhibition of collagenolysis by
protease inhibitor cocktail was near complete, the migration
efficiency of HT-1080/MT1 cells within 3D collagen lat-
tices was barely reduced (Fig. 3). Persistent migration was
monitored by sensitive real-time analysis of time-dependent
population speed (Fig. 3 A) and the median speed derived
from single cell analysis (Fig. 3 B). Similar high migration
rates were obtained by BB-2516 alone as well as from HT-
1080/
 
neo
 
 and wild-type cells in the presence of inhibitor
cocktail (unpublished data). Because the capacity to move,
i.e., to generate traction and overcome physical matrix con-
straints appeared intact after blocking of collagenolysis, we
hypothesized the existence of compensation strategies to
counterbalance the loss of pericellular proteolysis.
 
Induced amoeboid migration in vitro
 
As it became apparent from the video recordings (Video
3, available at http://www.jcb.org/cgi/content/full/
jcb.200209006/DC1), the presence of protease inhibitor
cocktail changed several aspects of migratory behavior in
HT-1080/MT1 cells (Fig. 4). Whereas spontaneously mov-
ing cells maintained a spindle-shaped, elongated morphology
(Fig. 4 A, left), this mesenchymal migration type was con-
verted to less polarized, more spherical morphodynamics in
the presence of protease inhibitor cocktail (Fig. 4 A, right;
Video 3). Spherical-shaped cells sustained migration (Fig. 4
B) and exhibited a significant reduction in median axis
length compared with control cells (Fig. 4 C). In the presence
of protease inhibitors, spherical morphodynamics included
flexible shape change and forward propulsion guided by mul-
tiple anterior and outward ruffling filopodia, as detected by
high resolution video microscopy (Video 4, available on-
line at http://www.jcb.org/cgi/content/full/jcb.200209006/
DC1). Very similar observations were obtained for invasive
 
Table I. 
 
Protease inhibitor cocktail
Inhibitor Target protease IC50 values Concentration Reference
 
 
 
M
 
 
 
M
 
BB-2516 MMPs
 
a
 
0.002–0.2 100
E-64 Cysteine proteases (cathepsin B, H, L, and K) 0.001–20 250 Bedi and Williams, 1994
Pepstatin A Aspartatic proteases (including cathepsin D) 0.0001–5 100 Laurent and Salzet, 1995; Nisbet and Billingsley, 1999
Leupeptin Cathepsin D 0.1–10 2
 
b
 
Bedi and Williams, 1994
Aprotinin Serine proteases (uPA and PA) 0.15–3.5 2.2
 
b
 
Callas et al., 1994
 
a
 
Guidelines for the clinical use of marimastat were from British Biotech Inc. (1998).
 
b
 
Highest nontoxic concentration (for details see Materials and methods).
Figure 3. Sustained migration in the presence of protease inhibitor 
cocktail. (A) Cell tracking analysis of the steady-state population 
speed   SD and (B) mean speed for each individual cell (time, 20 h; 
n   3 experiments, 120 cells).T
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MDA-MB-231 mammary carcinoma cells, expressing soluble
MMPs, MT-MMPs, serine proteases, and cathepsins (Ishiba-
shi et al., 1999; Bachmeier et al., 2001). Inhibition of pro-
teolysis in MDA-MB-231 cells by protease inhibitor cocktail
(Fig. 4 D), albeit slightly less efficient than in HT-1080 cells,
resulted in a similar transition from constitutive spindle
shape to less polarized, elliptoid morphodynamics (Fig. 4 E;
Video 5, available online at http://www.jcb.org/cgi/content/
full/jcb.200209006/DC1), including a significantly short-
ened median axis length (Fig. 4 F).
This novel nonproteolytic phenotype in HT-1080/MT1
and MDA-MB-231 cells was reminiscent of 
 
Dictyostelium
 
amoeba migrating across 2D surfaces (Yumura et al., 1984;
Killich et al., 1993) as well as leukocytes crawling through
3D ECM substrata (Gunzer et al., 2000; Friedl et al., 2001;
for comparison, see migrating T lymphocytes in Gunzer et
al. [2000] supplemental material). Morphometric analysis
showed a reduced number in mesenchymally moving cells in
the presence of protease inhibitor cocktail, whereas the per-
centage of the more spherical “amoeboid” phenotype was at
least tripled (Fig. 4 G) or doubled by BB-2516 alone (un-
published data).
 
Mechanisms of induced nonproteolytic migration
 
Consistent with impaired collagenolysis, amoeboid moving
HT-1080/MT1 cells did not cause structural remodeling
of collagen fibers (Video 6, available online at http://
www.jcb.org/cgi/content/full/jcb.200209006/DC1). In-
duced protease-independent migration resulted from adap-
tation and alignment of the cell body along preformed fiber
strands (Fig. 5 A, white arrowheads) and consecutive migra-
tory guidance along fibrillar scaffolds (Fig. 5 B, black arrow-
heads). Upon cell detachment, no remodeling, bundling, or
destruction of the collagen network was generated, leaving
behind the intact reticular texture of individual fibrils at
their original position (Fig. 5 A, black arrowheads; Video 6).
To overcome regions of narrow space by changing shape, an
initial pseudopod elongation through a preformed matrix
gap (4 
 
 
 
m pore diameter from the central section, 18 
 
 
 
m
cell diameter; Fig. 5 C, black arrowhead) was followed by
propulsion of the cell body and the development of a narrow
region confined by matrix fibers (constriction ring; Lewis,
1934; Fig. 5 C, black arrowhead). Constriction rings per-
sisted until the cell body had squeezed or pulled forward,
while no matrix defect was apparent after cell detachment
(Fig. 5 C; Video 7, available at http://www.jcb.org/cgi/
content/full/jcb.200209006/DC1).
Because the structure and location of adhesive cell–matrix
contacts control cell shape and migration dynamics (Palecek
et al., 1997; Sheetz et al., 1998), we investigated the cyto-
skeletal structure and integrin distribution in amoeboid HT-
1080/MT1 cells. Induced amoeboid morphology was char-
acterized by diffuse cortical actin rims and small actin-rich
spots at interactions with collagen fibers (Fig. 5 D). In
amoeboid HT1080/MT1 cells, 
 
 
 
1 integrins showed non-
clustered, linear surface distribution at contacts to collagen
Figure 4. Transition of spindle-shaped 
(mesenchymal) to more spherical 
(amoeboid) migration in HT1080/MT1 
and MDA-MB-231 cells in the presence 
of protease inhibitor cocktail. (A) Con-
version of elongated (left) toward spherical 
shape (right) in HT1080/MT1 cells, and 
(B) higher magnification of an amoeboid 
migrating cell in the presence of inhibitor 
cocktail. Time in B, 117 min. (C) Median 
elongation (calculated from length divided 
by width) in the absence and presence 
of protease inhibitor cocktail (n   3; 170 
cells; ***, P   0.0001). (D) Inhibition of 
collagen degradation by MDA-MB-231 
cells by protease inhibitor cocktail (n   3; 
P   0.05, unpaired two-tailed t test). 
(E) Conversion from spindle shaped (left) 
to more spherical morphology (right), 
and (F) reduced median elongation in 
the presence of protease inhibitors in 
MDA-MB-231 cells (n   3; 200 cells; 
***, P   0.0001). (G) Frequency of 
mesenchymal and amoeboid shape in 
actually migrating cells in the absence 
( ) and presence ( ) of protease inhibitor 
cocktail (HT-1080/MT1 cells, n   3, 100 
cells; **, P   0.001 for difference to 
untreated control; two-tailed t test for 
independent means). Cells of indeter-
minate morphology (15–40%; for details 
see the Materials and methods) were 
excluded from analysis. Bars: (A and E) 
100  m; (B) 20  m.T
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fibers (Fig. 5, D and E) deviating from clustered 
 
 
 
1 inte-
grins and prominent actin nucleation zones in spindle-
shaped control cells (Fig. 1 C; Fig. 5 F). MT1-MMP was
consistently dissociated from fiber binding sites but accumu-
lated intracellularly (Fig. 5 E).
 
Mesenchymal–amoeboid transition in vivo
 
Although collagen lattices provide a complex 3D ECM scaf-
fold and a barrier for moving cells, a putatively different
spacing and molecular composition of life connective tis-
sue may impose additional physical and molecular con-
straints, putatively yielding in distinct migration mechanisms.
Therefore, the in vivo migration of HT-1080/MT1 cells
within the mouse dermis was investigated by multiphoton
microscopy. 3 h after the injection of HT-1080/MT1 cells
into the loose connective tissue of the mouse dermis (Fig. 6
A), both nontreated control cells (green) and cells pretreated
with protease inhibitor cocktail (red) were detected at and
passively scattered around the injection site (Fig. 6 A, aster-
isk), or located within multicellular cords (Fig. 6 A, black ar-
rowheads). In wash-out experiments in vitro, preincubation
of cells with protease inhibitor cocktail for 6 h resulted in
stable amoeboid movement for at least 10 h before rever-
sion toward mesenchymal migration occurred (unpublished
data), indicating both relatively slow turnover of the target
proteases after inhibition and full reversibility of inhibitor-
induced phenotypic change. In the dermis, ortotopic 3D re-
construction of the injection site 3 and 8 h after injection
identified considerable position changes for both control
cells (Fig. 6 B, top) and inhibitor-pretreated HT-1080/MT1
cells (Fig. 6 B, bottom). This position change corresponded
to a translocation of 4–10 
 
 
 
m/hr (Fig. 6 B, white arrow-
heads), in part approximating migration velocities present in
collagen matrices in vitro (6–36 
 
 
 
m/h; compare Fig. 3 B).
At high-resolution reconstruction, cells pretreated with pro-
tease inhibitors developed a significantly reduced elongation,
reminiscent of amoeboid morphology (Fig. 6 C, red cells),
and a near-round median shape (Fig. 6 D), whereas control
cells retained their constitutive spindle-like elongation (Fig.
6 C, green cells; Video 8, available at http://www.jcb.org/
cgi/content/full/jcb.200209006/DC1). In summary, simi-
lar to 3D collagen matrices, abrogation of matrix protease
function in HT-1080/MT1 cells was followed by cell move-
ment and concomitant induction of amoeboid morphology
Figure 5. Cellular mechanism of non-
proteolytic movement within 3D collagen 
matrix and related changes in  1 integrin, 
MT1-MMP, and F-actin distribution 
in HT-1080/MT1 cells. (A) Induced 
amoeboid migration lacking fiber 
degradation. Alignment of cell body 
along a fiber strand (white arrowheads) 
and intact individual collagen fiber at 
its original position after cell detachment 
(black arrowhead). (B) Migratory align-
ment of the cell depicted in A along the 
preexisting fiber scaffold. The outline 
of the cell edge at 2.5-min time intervals 
(blue lines) was superimposed onto the 
3D reconstruction of the transmigrated 
matrix structure. Bright pixels indicate 
colocalization of cell boundary and 
fibers (arrowheads). (C) Migration through 
a narrow gap bordered by fibers (black 
arrowhead) resulting in morphological 
adaptation and the formation of a 
constriction ring. (D) Reduced F-actin 
and  1 integrin focalization at fiber 
binding sites in an amoeboid HT1080/
MT1 cell, compared with F and Fig. 1 C. 
Because of constriction caused by a 
perpendicular collagen fiber, this cell 
contains a lobulated main body. Black 
arrowhead, uropod. (E) Loss of clustered 
MT1-MMP and  1 integrins from inter-
actions with fibers in induced amoeboid 
migration. Arrowheads indicate two 
simultaneous constriction rings bordered 
by perpendicular collagen fibers. 
(F) F-actin and  1 integrins in an 
untreated control cell of elongated 
shape. Time: (A) 35 min; (B) 65 min; 
(C) 20 min. Bars, 20  m. Black arrows, 
direction of migration.T
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in vivo, confirming migratory plasticity for dermal connec-
tive tissue.
 
Discussion
 
The transition from proteolytic and “mesenchymal” to pro-
tease independent and “amoeboid” movement reveals a
novel cellular and molecular adaptation pathway in sustain-
ing cell migration: the switch from a path-generating to a
path-finding migration mode that we have termed mesen-
chymal–amoeboid transition (MAT). Although proteases
were used for constitutive migration of proteolytic cells of
mesenchymal and epithelial origin, abrogation of pericellu-
lar proteolysis was followed by nonproteolytic movement.
MAT thus represents a compensatory migration mode in
vitro and in vivo to bypass physical matrix resistance by
amoeboid shape change.
 
Constitutive proteolytic migration of mesenchymal cells
 
Important concepts on cell migration are derived from the
movement of fibroblasts and myoblasts (Lauffenburger and
Horwitz, 1996). In 3D in vitro and in vivo tissues, fibro-
 
blasts develop elongated, spindle-shaped morphology medi-
ated by cortical F-actin and occasional stress fibers (Welch
et al., 1990). Fibroblast migration is dependent on 
 
 
 
1 inte-
grin function (Doane and Birk, 1991) and is further cou-
pled to the cleavage and remodeling of ECM components
using MMPs and other proteases (Langholz et al., 1995). A
similar type of mesenchymal behavior is developed by HT-
1080 fibrosarcoma cells and MDA-MB-231 mammary car-
cinoma cells in 3D collagen matrices. These cells move as
individual spindle-shaped cells that utilize 
 
 
 
1 integrin–
mediated binding to collagen fibers for elongation and trans-
location. Similarly to fibroblasts, a range of ECM-degrading
enzymes is expressed, coclustered with integrins at interac-
tions to substrate, and used for the generation of tube-like
matrix defects that correspond to known clearance tracks in
other models (Nakahara et al., 1997; d’Ortho et al., 1998).
Because the cell diameter of mesenchymal-like cells exceeds
the mean pore size within the fiber network (Friedl et al.,
1997), contact-dependent focal degradation of collagen
barriers may facilitate migration by locally lowering the
physical resistance of the ECM barrier (Murphy and
Gavrilovic, 1999).
Figure 6. In vivo translocation and morphology of HT-1080/MT1 cells in the mouse dermis. Intravital microscopy of ECM structure (light 
brown) and labeled cells 3 h (A–D) and 8 h (B) after injection. (A) 3D reconstruction of injection site (asterisk), more distant cells passively 
scattered around the injection site, and matrix structure at low magnification (10  objective). Control cells (green) and cells pretreated with 
protease inhibitor cocktail (red). Asterisk, center of injection site. Black arrows, multicellular cord. (B) Position change of control cells (top) 
and cells pretreated with protease inhibitor cocktail (bottom) from the injection site depicted in A. False-color reconstruction was obtained for 
each fluorescence channel 3 h (green) and 8 h (red) after injection. Orthotopic superimposition was controlled by the position of coinjected 
fluorescent beads (circles) as well as the multicellular cord. White arrowheads, regions of cell translocation (right). (C) High resolution imaging 
of cell morphology and (D) elongation of control cells (green) and cells pretreated with protease inhibitor cocktail (red) at least 2 h after injection 
(40  objective). Elongation was calculated from 170 cells, six independent experiments; ***, P   0.0001. Bars: (A and B [left]) 200  m; 
(B [right] and C) 100  m.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
274 The Journal of Cell Biology 
 
|
 
 
 
Volume 160, Number 2, 2003
 
Constitutive nonproteolytic amoeboid 
migration strategies
 
In some cell types, migration results from more dynamic,
transient and less defined cell–substrate contacts associated
with amoeboid shape (Friedl and Bröcker, 2000; Friedl et
al., 2001; and references therein). The concept of amoeboid
movement is most clearly established from the single cell
state of the lower eukaryote 
 
Dictyostelium discoideum
 
. 
 
Dic-
tyostelium
 
 is an elliptoid cell that translocates via rapidly al-
ternating cycles of morphological expansion and contrac-
tion, relatively low-affinity integrin-independent interactions
with the substrate, and extraordinary deformability (Yumura
et al., 1984; Devreotes and Zigmond, 1988; Killich et al.,
1993; Friedl et al., 2001). In higher eukaryotic cells, such as
leukocytes and certain types of tumor cells, hallmarks of
amoeboid motion are retained, including rapid low affinity
gliding coupled to shape change, squeezing through pre-
formed matrix gaps, and propulsive elongation along paths
of least resistance (Lewis, 1934; Schor et al., 1983; Friedl et
al., 1998, 2001). In collagen matrices, T cell migration is in-
dependent of structural matrix remodeling (Schor et al.,
1983) and it is not sensitive to protease inhibitor treatment
(unpublished data) or the inhibition of 
 
 
 
1 integrin function,
the latter both in vitro and in vivo (Friedl et al., 1998;
Brakebusch et al., 2002). Thus, amoeboid migration appears
to comprise morphodynamic supramolecular mechanisms to
bypass tissue barriers independent of ECM degradation.
 
Mesenchymal–amoeboid transition: 
induced amoeboid migration
 
In HT-1080 fibrosarcoma and MDA-MB-231 mammary
carcinoma cells, the mechanism of sustained migration after
abrogation of pericellular proteolysis was a striking change
in cell morphology and migration “style” reminiscent of
transition toward amoeboid movement. To provide maxi-
mum inhibition efficiency, five pharmacological inhibitors
were used to simultaneously target different protease classes
known to contribute to ECM degradation and remodeling,
including MMPs, serine proteases, and cathepsins, all of
which are expressed by HT-1080 and MDA-MB-231 cells.
We reasoned that more specific approaches, such as genetic
ablation of individual proteases, might be hampered by pro-
teolytic redundancy and functional compensation.
The effectiveness of the protease inhibition strategy was
shown by a combined biochemical and structural approach:
(a) near-total inhibition of FITC release using FITC-labeled
fibrillar collagen; (b) abrogation of macroscopic structural
degradation of the collagen lattice by HT-1080 cells; and
(c) the lack of newly generated tube-like matrix defects in
the wake of the cells visualized by 4D confocal backscatter
microscopy.
Inhibition of constitutive proteolysis, instead of causing
the cells to become “trapped” within the fibrillar network,
induced a program of morphodynamic and molecular
changes that allowed the maintenance of the migratory ac-
tion (Fig. 7). These changes included a reduced elongation
yet increased morphodynamic flexibility, the loss of focal 
 
 
 
1
integrin and MT1-MMP clustering at interactions with ma-
trix fibers, and a more diffuse cortical actin distribution, in-
cluding small actin-rich nucleation foci at fiber binding sites.
These features are coupled to the forward flow (streaming)
of cytoplasm through cell regions of narrow space confined
by outside constriction and, together, result in a phenotype
mimicking amoeboid moving cells (Yumura et al., 1984;
Devreotes and Zigmond, 1988; Killich et al., 1993; Friedl et
al., 2001). Because this induced amoeboid behavior gener-
ated significant migratory activity, yet the transmigrated col-
lagen architecture remained intact by means of biochemical
and structural analysis, our data show an alternative inhibi-
tor-induced nonproteolytic migration type (Fig. 7).
Induced protease-independent movement was observed
for two different collagen-based tissue models, 3D collagen
lattices in vitro and the mouse dermis in vivo. As recon-
structed by intravital microscopy, the loose connective tissue
of the mouse dermis exhibits strong structural similarity to
3D collagen matrices. Both models provide 3D fibrillar col-
lagenous strands bordering matrix gaps in the range of 1–15
 
 
 
m (unpublished data). Migratory alignment and shape
change of tumor cells (cell diameter in the range of 15–25
 m [Friedl et al., 1997]; 10–30-fold larger in volume than
amoeba or leukocytes) along preformed fiber strands may
hence be sustained by constriction of the cell body and pro-
pulsion of the cytoplasm through narrow space as a nonpro-
teolytic, physical strategy to bypass structural ECM barriers.
Although the spacing of such loose connective tissue sup-
ports protease-independent cell movement, future studies
will be necessary to determine under which conditions trans-
migration of more densely interconnected ECM, such as
basement membranes, can occur by nonproteolytic means.
The finding that blocking proteases induces transition
from a mesenchymal phenotype to amoeboid movement
sheds light on how disseminating tumor cells may react in
response to protease inhibitor–based therapy. In established
tumor disease, tumor cells have already reached interstitial
tissue compartments (Stetler-Stevenson et al., 1993) that are
likely to support shape-driven migration independent of
pericellular proteolysis. Therefore, protease-independent tu-
mor cell dissemination may represent a candidate escape
Figure 7. Concept on mesenchymal–amoeboid transition. A program 
of morphodynamic and molecular changes after abrogation of peri-
cellular proteolysis by protease inhibitors provides a supramolecular 
mechanism for persistent nonproteolytic migration in 3D fibrillar 
collagenous tissues.T
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mechanism upon protease inhibitor–based treatment of pro-
gressive cancer disease (Zucker et al., 2000; Kruger et al.,
2001; Coussens et al., 2002).
Molecular implications of MAT
The putative mechanistic link between loss of pericellular
proteolysis and MAT can be best explained by changes in
cell–matrix interaction strength. Although different experi-
mental systems are difficult to directly relate, exaggerated
mesenchymal-like phenotypes can be induced by strength-
ening cell–ECM contacts or reducing their turnover: by sta-
bilizing interactions toward collagen fibers after arresting  1
integrins in a high-affinity ligand-bound state (Maaser et al.,
1999) or by stabilizing stress fibers leading to spread-out,
elongated morphology through activation of the small GTP-
ase Rho (Nobes and Hall, 1999). Conversely, reduced axis
length and amoeba-like morphodynamics may emerge from
weakening substrate-binding strength: by reducing integrin
adhesive function (Dufour et al., 1988) or by inhibiting
Rho-kinase (Nobes and Hall, 1999). In addition to inte-
grins, several of the proteases blocked in this study are
known to regulate cellular morphodynamics by other mech-
anisms, including a mesenchymal phenotype (Lochter et al.,
1997). MMP-3 overexpression in epithelial cells leads to the
cleavage of E-cadherin and induces epithelial–mesenchymal
transition, i.e., single cell detachment and mesenchymal in-
vasion (Lochter et al., 1997). Proteases further control cell
adhesion, cytoskeletal organization, and the release of solu-
ble factors (Sternlicht and Werb, 2001; and references
therein). These functions comprise cleavage of adhesion re-
ceptors (e.g., L-selectin); cleavage and activation of cytokines
(e.g., IL-1 and TNF- ) or growth factors (e.g., EGF and
bFGF); and the regulation of focal contact assembly and
turnover by cleavage of talin or integrin cytoplasmic do-
mains through, for example, calpain. The identification of
pathways involved in MAT will thus require further studies
on different cytoskeletal and signaling checkpoints that con-
trol cell shape and cell–matrix interactions.
MAT: comparison to other morphodynamic processes
Plasticity and adaptation in cell behavior are well established
in other morphodynamic processes governed by cell–cell
and cell–substrate interactions. In epithelial–mesenchymal
transition, a usually nonmigrating epithelial collective aban-
dons cell–cell cohesion after cadherin-mediated cell–cell
contacts are weakened, allowing detachment of single cells
and conversion toward mesenchymal morphology and mi-
gration (Birchmeier and Birchmeier, 1995). In another ex-
ample, differentiating muscle precursor cells quit cell move-
ment and fuse via N- and E-cadherin to form a multicellular
contractile syncythium (Redfield et al., 1997). In conclu-
sion, MAT may represent a novel transient morphodynamic
alteration and adaptation pathway in molecular cell dynam-
ics. Stringent, adhesive, and proteolytic cell–ECM contacts,
as developed by mesenchymally moving cells, can be con-
verted toward less well characterized, more diffuse, and less
proteolytic interactions with extracellular scaffolds, reminis-
cent of amoeboid single cell movement. Residual amoeboid
movement may hence represent a robust “salvage” pathway
of cell movement in loose connective tissue after the abroga-
tion of pericellular proteolysis.
Materials and methods
Cell migration in 3D collagen matrices: reconstruction by 
time-lapse video microscopy and confocal microscopy
Subconfluent HT-1080 fibrosarcoma cells stably transfected with MT1-
MMP (Deryugina et al., 1997) or MDA-MB-231 breast carcinoma cells
(Ishibashi et al., 1999; Bachmeier et al., 2001) were detached by EDTA (2
mM), washed, incorporated into 3-D collagen lattices (1.67 mg/ml; native
dermal bovine type I collagen; Vitrogen; Cohesion Inc.), and monitored by
time-lapse video microscopy (Friedl et al., 1997; Gunzer et al., 2000). The
collagen was resistant to trypsin and sensitive to degradation by MT1-
MMP (not depicted), confirming its native state. HT-1080/MT1 cells served
as model for high constitutive collagenase expression and activity, allow-
ing a robust visualization of surface MT1-MMP and fiber breakdown in the
process of migration. In control experiments, HT1080/neo cells as well as
HT-1080 wild-type cells were used for collagen degradation and migration
experiments yielding similar results, including MAT (not depicted). For in-
hibition studies, blocking anti– 1 integrin mAb 4B4 (10  g/ml; Coulter) or
protease inhibitor cocktail (Table I) was added to the lattice before poly-
merization as well as to the supernatant. Protease inhibitor cocktail con-
sisted of BB-2516 (marimastat; provided by British Biotech Inc.), leupeptin
(Molecular Probes), pepstatin A, E-64, and aprotinin (all from Sigma-
Aldrich). Protease inhibitor cocktail did not affect cell viability in collagen
after 48 h, as assessed after cell release from the collagen lattice by colla-
genase digestion, propidium iodide staining, and flow cytometry, or upon
liquid culture after 72 h of exposure.
For 3D time-lapse confocal microscopy (Leica-SP2 system), cells within
the lattice were labeled by calcein-AM (1  M), scanned at 2.5-min time
intervals for simultaneous fluorescence and backscatter signal, and recon-
structed (Friedl et al., 1997). MT1-MMP and  1 integrins were detected by
rabbit AB815 (Chemicon), secondary rhodamine-conjugated goat anti–
rabbit Fab’ fragments (Jackson ImmunoResearch Laboratories), and a cock-
tail of FITC-labeled mAb 4B4 and K20 (Coulter), respectively.
Computer-assisted cell tracking and reconstruction 
of cell morphology
Locomotor parameters were obtained by computer-assisted cell tracking
and reconstruction of the x and y coordinates of the cell paths (Maaser et
al., 1999). The population speed was calculated from each 15-min track-
ing interval for all cells divided by the number of cells. Single cell speed
represents the total length of the path divided by time. The proportion of
mesenchymal to amoeboid migration was assessed 9 h (HT1080/MT1) or
18 h (MDA-MB-231) after addition of protease inhibitor cocktail by visual
blinded analysis for a 60-min time interval by two independent observers.
Cells of indeterminate morphology representing either transition states of
partially elongated, dividing, or nonmigrating cells precluded clear catego-
rization and were excluded from analysis (15–40% of total population). In
control cells, indeterminate morphology was seen in 20% of the cells,
mainly representing dividing cells and periods of retraction of otherwise
elongated mobile cells (see Video 3). In the presence of inhibitor cocktail,
the indeterminate fraction was increased to 40%, containing an additional
subset of partially retracted cells (elongation index  2) that lacked the cri-
teria of full amoeboid as well as mesenchymal morphodynamics (Video 3).
Elongation was calculated from still frames as elongation index for each
cell (axis length divided by width) and displayed as box-blot ranging from
the 25th to 75th percentile including the median and whiskers from the
5th to 95th percentile. Unless indicated otherwise, statistical analysis was
performed using the unpaired two-tailed Mann-Whitney U test.
RT-PCR
Primers and RT-PCR conditions were used as previously described (Hof-
mann et al., 1999; Konttinen et al., 1999; McCulloch et al., 2000). Addi-
tional primers were cathepsin B, 5 -GCCTGCAAGCTTCGATGCAC-3  (di-
rect) and 5 -CTATTGGAGACGCTGTAGGA-3  (reverse); cathepsin D, 5 -
CCAGCCCCCAATCCCAACCCCACCTCCAG-3  (direct) and 5 -CACT-
GAAGCTGGGAGGCAAAGGCTACAAGC-3  (reverse); cathepsin K, 5 -TCC-
ATCCATAACCTTGAGGCTT-3  (direct) and 5 -CCACAGCCATCATTCT-
CAGACACA-3  (reverse); cathepsin L, 5 -CAGGCAGGTGATGAATGGCT-
3  (direct) and 5 -CAGGCCTCCATTATCCTGAA-3  (reverse); MT1-MMP,
5 -CCCTATGCCTACATCCGTGA-3  (direct) and 5 -TCCATCCATCACTTG-
GTTAT-3  (reverse); u-PAR, 5 -GGTCACCCGCCGCTG-3  (direct) and 5 -T
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CCACTGCGGTACTGGACA-3  (reverse); u-PA, 5 -AAAATGCTGTGTGCT-
GCTGACC-3  (direct) and 5 -CCCTGCCCTGAAGTCGTTAGTG-3  (re-
verse); and PAI-1, 5 -GAACAAGGATGAGATCAGCACC-3  (direct) and 5 -
ACTATGACAGCTGTGGATGAGG-3  (reverse). Uniqueness of region was
confirmed using the NCBI blastn program; specificity was determined from
the length of each PCR product. Total RNA was isolated (QIAGEN RNA-
Easy kit), transcribed to cDNA by AMV reverse transcriptase, and amplified
by PCR (30 cycles). Absence of cDNA contamination was confirmed by
subjecting total cell lysates to PCR in the absence of reverse transcriptase.
Collagen degradation assays
HT-1080/MT1 or MDA-MB-231 cell suspension was copolymerized with
nonlabeled rat tail collagen (Becton Dickinson) containing 2% FITC-
labeled collagen monomers (Molecular Probes). After migration for 40 h,
solid-phase collagen containing the cells was pelleted, while FITC released
into the supernatant was analyzed by spectrofluorometry. 100% values
were obtained by complete collagenase digestion of cell-free collagen lat-
tices. Background fluorescence was calculated by pelleting nondigested
cell-free lattices. No autofluorescence was detected for either cells or in-
hibitors. FITC–collagen was sensitive to degradation by recombinant MT1-
MMP, MMP-2, and trypsin. While FITC release detected both classical
collagenases as well as trypsin-like activity, FITC release induced by HT-
1080/MT1 cells was reduced by 80% by the MMP inhibitor BB-2516 (Fig.
2 C), indicating MMPs as primary collagenases in these cells. To exclude
that FITC release merely reflected telopeptidase activity and incomplete fi-
ber degradation, 500,000 HT1080/MT1 cells in a drop of medium were
placed onto native nonlabeled 3D collagen (100  m in depth). Fiber
breakdown was detected after 40 h by Coomassie blue staining and confo-
cal backscatter microscopy.
Intravital multiphoton microscopy
Reconstruction of HT1080/MT1 cell positioning and ECM structure were
monitored by multiphoton microscopy (Maiti et al., 1997) of the mouse
dermis in adult C57BL/6 mice, using a novel modification of a bone mar-
row intravital video microscopy model (Mazo et al., 1998). The epidermis
and upper dermis, including hair follicles of the frontoparietal scalp, were
removed by careful separation from the underlying connective tissue using
microscissors. A fixation ring was inserted into the incision to spread the
skin, and Hepes-buffered medium containing 10% fetal bovine serum was
applied. Subconfluent HT-1080/MT1 cells were preincubated for 3–4 h in
protease inhibitor cocktail (each 20  M BB-2516, pepstatin A, E-64, 0.7
 M aprotinin, 2  M leupeptin) or medium alone. Control cells and inhibi-
tor cocktail–treated cells were labeled with calcein-AM (green) or TRITC
(red), respectively, washed twice, suspended together in medium (10
4
cells/3  l each), and carefully injected into the mid-dermis over the immo-
bilized mouse scull. After injection, a temperature of 37 C was maintained
by a water circulation system through the fixation ring and the use of a
tempered water immersion objective. Intravital multiphoton microscopy
was performed on an Olympus BX 50 WI microscope coupled to a Ti:Sap-
phire laser (Spectraphysics) and a Radiance 2000MP confocal multiphoton
imaging system controlled by the Lasersharp software (all from Bio-Rad
Laboratories). Multiphoton excitation light of 800 nm was introduced into
the sample. Connective tissue structures were visualized via autofluores-
cence and second harmonic generation imaging at 400/40 nm. Labeled tu-
mor cells were detected at 525/30 nm (calcein-AM) and 600/100 nm
(TRITC). Image reconstruction from z-series scans up to a penetration
depth of 800  m was performed using the freeware Confocal Assistant
©.
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